
Collaborative ILD Care: Bridging Pulmonology and Rheumatology
Event Date
October 30, 2025
Location
Virtual Live Event
Event Time
12:00-1:00pm, MST
Completion Time
60 minutes
Specialty
Pulmonology
Topic(s)
Interstitial Lung Disease, Pulmonary Fibrosis
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
All other healthcare professionals completing this course will be issued a statement of participation.
Program Overview
Collaborative ILD Care: Bridging Pulmonology and Rheumatology is a program that supports community and academic pulmonologists and rheumatologists by fostering a community of practice focused on early diagnosis, evidence-based treatment, and multidisciplinary collaboration. Program registrants have access to three core program components:
The live virtual meetings are interactive, case-based discussions that connect expert faculty with community and academic clinicians. Held three times during the program, these sessions focus on real patient cases—both those submitted by participants and those shared by faculty—covering ILD diagnosis, treatment strategies, and multidisciplinary collaboration. Guided by pulmonologists and rheumatologists, the meetings provide practical insights, foster peer-to-peer exchange, and strengthen professional networks. Recordings will be available for later review, ensuring all learners can benefit from the conversations and apply evidence-based strategies in their own clinical practice.
*Register now by clicking the 'Start Activity' button*
Learning Objectives
Upon completion of this activity, participants should be able to:
- Recognize signs, symptoms, and risk factors for ILD.
- Apply evidence-based diagnostic strategies to provide timely and accurate diagnosis of ILD.
- Implement multidisciplinary approaches for the early identification of and treatment of ILD.
- Appy up-to-date guidelines for the treatment of ILD.
- Evaluate current and emerging approaches for ILD treatment.
Program Chairs

Zulma X. Yunt, MD
Associate Professor
Department of Medicine, Division of Pulmonary, Critical Care & Sleep Medicine,
Clinic Director, Interstitial Lung Disease Program
Medical Director, Office of Professional Education
National Jewish Health
Denver, Colorado

Barbara Goldstein, MD, MMSc
Physician
Denver Arthritis Clinic
Denver, Colorado
Accreditation Statement

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
Physician Credit Designation Statement
National Jewish Health designates each live event for a maximum of 1.0 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Disclosures of Conflicts of Interest
In accordance with the Accreditation Council for Continuing Medical Education (ACCME), National Jewish Health requires that all program faculty, content developers, reviewers, and others in a position to control the content of this activity disclose to learners the presence or absence of any relevant financial relationships with an ACCME-defined ineligible company within the preceding 24 months of the activity. The ACCME defines an “ineligible company” as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Our goal is to ensure that there is no compromise in the ethical relationship that exists between those in a position to control the content of the activity and those participating in the activity and their respective professional duties. All accredited education activities offered by National Jewish Health are reviewed to ensure a balanced and evidence-based presentation.
All relevant financial relationships among individuals in a position to control the content of this activity have been identified and mitigated according to the Standards of Integrity and Independence in Accredited Continuing Education.
Program Chairs Disclosures
Barbara Goldstein, MD, MMSc has no relevant financial relationships to disclose
Zulma X. Yunt, MD reports the following relevant financial relationships:
- Speaker: Boehringer Ingelheim
- Consultant: Johnson & Johnson
Planner and Reviewer Disclosures
Meghan Brenner, MA has no relevant financial relationships to disclose.
Bryce Chitanavong, MBA has no relevant financial relationships to disclose.
Andrea Harshman, MHA, CHCP has no relevant financial relationships to disclose.
Michael Mohning, MD reports the following relevant financial relationships:
- Investigator: Bristol Myers Squibb
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- 3. Complete the post-test and submit the evaluation form.
A certificate will be emailed to the participant.
Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
Disclaimer
National Jewish Health (“NJH”) and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, “NJH Parties”) shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.
By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product.
Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.
Contact Information
For CME questions please contact: [email protected].